Repurposing pentoxifylline for the treatment of fibrosis: an overview
Fibrosis is a potentially debilitating disease with high morbidity rates. It is estimated that half of all deaths that occur in the USA are attributed to fibrotic disorders. Fibrotic disorders are characterized primarily by disruption in the extracellular matrix deposition and breakdown equilibrium,...
Main Authors: | Wen, W, Lee, S, Siang, R, Koh, R |
---|---|
Formato: | Journal article |
Idioma: | English |
Publicado: |
Springer Nature
2017
|
Títulos similares
-
Pentoxifylline in patients with oral submucous fibrosis
por: Ashwini Deshpande, et al.
Publicado: (2015-01-01) -
Efficacy of pentoxifylline in the management of oral submucous fibrosis
por: Santosh Patil, et al.
Publicado: (2014-01-01) -
Pentoxifylline Inhibits Pulmonary Fibrosis by Regulating Cellular Senescence in Mice
por: Yifan Lin, et al.
Publicado: (2022-05-01) -
Pentoxifylline in the Treatment of Acute Alcoholic Hepatitis
por: Arun S, et al.
Publicado: (2014-07-01) -
Pentoxifylline: An Immunomodulatory Drug for the Treatment of COVID-19
por: Hiren A. Dhameliya, et al.
Publicado: (2020-05-01)